Opentrons announces $200 million Series C funding | READ MORE
Zenith is building a Bio Studio that will enable non-experts to rapidly build and deploy purpose-built AI applications for future Biotechnology.
Our vision is to be the standard for end-to-end AI creation that delivers in the real world. We have a clear focus on Life Sciences users and challenges, such as Robotics, Synthetic Biology and Diagnostics.
Founded in 2020 by a team of well experienced and world-renowned machine learning entrepreneurs, our team has rapidly progressed the development of our software platform.
At Zenith the customer experience comes first; to truly democratise AI requires a tool that is wholly intuitive and light-years ahead of the tooling used today.